Pim M.
- Country
- The Netherlands
- Department
- Hematology
Research Overview
- Safety and Dosing Evaluation of KITE-363 and KITE-753 in Relapsed/Refractory B-cell Lymphoma Patients
- Safety Evaluation of REGN5837 Combined with Odronextamab in Patients with Aggressive B-cell Non-Hodgkin Lymphomas
- A phase I/II, multicenter study evaluating the feasibility, safety, and efficacy of point-of-care manufactured GLPG5101 (19CP02) in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma
Data & Insights
Has run more than one trial at 73 of 189 partner sites.
Specializations
Lymphoma Research
The investigator specializes in treating various forms of lymphoma, with particular focus on advanced Hodgkin lymphoma and B-cell non-Hodgkin lymphoma. Their research encompasses innovative therapeutic approaches for both initial treatment and relapsed/refractory cases.
- Advanced Stage Hodgkin Lymphoma Management
- Aggressive B-cell Non-Hodgkin Lymphoma
- Relapsed/Refractory Mantle Cell Lymphoma
Their work includes evaluation of targeted therapies and response-adapted treatment strategies.
Cell Therapy Innovation
The investigator conducts research in gene-modified T cell therapies for hematological malignancies. Their expertise extends to monitoring long-term outcomes and safety profiles of cellular therapeutics.
- Gene-Modified T Cell Applications
- CAR-T Cell Therapy
- Long-term Safety Monitoring
Their research includes evaluation of novel cellular therapies for various lymphoma subtypes.
Rare Blood Disorders
The investigator studies rare hematological conditions, including Hypereosinophilic Syndrome (HES). Their research involves testing novel biological therapies for these uncommon blood disorders.
- Hypereosinophilic Syndrome Treatment
- Targeted Biological Therapies
- Novel Treatment Approaches
Their work focuses on developing effective treatments for patients with rare hematologic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.